Parallax Volatility Advisers, L.P. Mirati Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $300,240 - $489,780	10,800 New	10,800 $470,000
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $2.17 Million - $5.19 Million	52,600 Added 307.6%	69,700 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $1.02 Million - $1.48 Million	17,100 New	17,100 $1.2 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $8.58 Million - $12.4 Million	65,000 Added 283.84%	87,900 $12.9 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $7.54 Million - $10.1 Million	-57,100 Reduced 71.38%	22,900 $4.05 Million

Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $13 Million - $19.2 Million	80,000 New	80,000 $17.6 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $7,201 - $12,039	-100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $153,516 - $255,662	-2,200 Reduced 95.65%	100 $8,000
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $5.32 Million - $9.69 Million	-75,200 Reduced 97.03%	2,300 $297,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $4.61 Million - $8.12 Million	77,500 New	77,500 $7.98 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $800,000 - $1.19 Million	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $1.06 Million - $1.41 Million	-22,500 Reduced 47.37%	25,000 $1.18 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $1.24 Million - $2.49 Million	47,500 New	47,500 $2.34 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.